Tech Company Financing Transactions
Magenta Therapeutics Funding Round
Magenta Therapeutics, based in Cambridge, secured $48.5 million from Atlas Accelerator, Third Rock Ventures and Access Industries.
Transaction Overview
Company Name
Announced On
11/17/2016
Transaction Type
Venture Equity
Amount
$48,500,000
Round
Series A
Investors
Atlas Accelerator (Lead Investor) (Bruce Booth)
Third Rock Ventures (Lead Investor) (Alexis Borisy)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Technology Sq. 5th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Gardner
Chief Medical Officer
John Davis
Chief Operating Officer
Jason Ryan
Vice President
Manisha Pai
VP - Bus. Development
Christina Isacson
VP - General Counsel
Zoran Zdraveski
VP - Human Resources
Kristen Stants
Browse more venture capital transactions:
Prev: 11/17/2016: Phononic Devices venture capital transaction
Next: 11/17/2016: Zwift venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs